These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1032 related items for PubMed ID: 9541487

  • 1. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN.
    J Clin Invest; 1998 Apr 15; 101(8):1581-90. PubMed ID: 9541487
    [Abstract] [Full Text] [Related]

  • 2. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb 15; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 3. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M, Karry R, Aviram M.
    Atherosclerosis; 2006 Jul 15; 187(1):74-81. PubMed ID: 16229851
    [Abstract] [Full Text] [Related]

  • 4. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
    Ng CJ, Hama SY, Bourquard N, Navab M, Reddy ST.
    Mol Genet Metab; 2006 Dec 01; 89(4):368-73. PubMed ID: 16935014
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages.
    Lin KY, Chen YL, Shih CC, Pan JP, Chan WE, Chiang AN.
    J Cell Biochem; 2002 Dec 01; 86(2):258-67. PubMed ID: 12111995
    [Abstract] [Full Text] [Related]

  • 9. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F, Zago V, Verona J, Muzzio ML, Wikinski R, Schreier L.
    Life Sci; 2006 May 22; 78(26):3074-81. PubMed ID: 16488445
    [Abstract] [Full Text] [Related]

  • 10. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
    Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B.
    Free Radic Biol Med; 1999 Apr 22; 26(7-8):892-904. PubMed ID: 10232833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
    Navab M, Hama-Levy S, Van Lenten BJ, Fonarow GC, Cardinez CJ, Castellani LW, Brennan ML, Lusis AJ, Fogelman AM, La Du BN.
    J Clin Invest; 1997 Apr 15; 99(8):2005-19. PubMed ID: 9109446
    [Abstract] [Full Text] [Related]

  • 13. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
    Rodríguez Esparragón F, Hernández Trujillo Y, Macías Reyes A, Hernández Ortega E, Medina A, Rodríguez Pérez JC.
    Rev Esp Cardiol; 2006 Feb 15; 59(2):154-64. PubMed ID: 16540037
    [Abstract] [Full Text] [Related]

  • 14. Protective effect of human HDL against Cu(2+)-induced oxidation of astrocytes.
    Ferretti G, Bacchetti T, Moroni C, Vignini A, Curatola G.
    J Trace Elem Med Biol; 2003 Feb 15; 17 Suppl 1():25-30. PubMed ID: 14650625
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, Hofman A, Rosenblat M, Volkova N, Presser D, Attias J, Hayek T, Fuhrman B.
    Drugs Exp Clin Res; 2002 Feb 15; 28(2-3):49-62. PubMed ID: 12224378
    [Abstract] [Full Text] [Related]

  • 17. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
    Ferretti G, Bacchetti T, Marotti E, Curatola G.
    Metabolism; 2003 Feb 15; 52(2):146-51. PubMed ID: 12601623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins.
    Oda MN, Bielicki JK, Ho TT, Berger T, Rubin EM, Forte TM.
    Biochem Biophys Res Commun; 2002 Jan 25; 290(3):921-7. PubMed ID: 11798161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.